Horizon Pharma plc
May 26, 2017

Horizon Pharma plc to Participate in Upcoming Conferences

DUBLIN, Ireland, May 26, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will participate at the following conferences in June:

Jefferies 2017 Global Healthcare Conference

The JMP Securities Life Science Conference

The conferences presentations will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.  

About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs.  The Company markets 11 medicines through its orphan, rheumatology and primary care business units.  For more information, please visit www.horizonpharma.com.  Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

Contacts:

Investors:U.S. Media:
Tina VenturaGeoff Curtis
Senior Vice President,Senior Vice President,
Investor RelationsCorporate Affairs & Chief Communications Officer
investor-relations@horizonpharma.commedia@horizonpharma.com        
  
Ruth VenningIreland Media:
Executive Director,Ray Gordon
Investor RelationsGordon MRM
investor-relations@horizonpharma.com                     ray@gordonmrm.ie


Primary Logo

Source: Horizon Pharma plc

News Provided by Acquire Media